U.S. flag

An official website of the United States government

NM_000796.6(DRD3):c.25G>A (p.Gly9Ser) AND Essential tremor, susceptibility to

Germline classification:
risk factor (1 submission)
Last evaluated:
Mar 6, 2007
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000018258.2

Allele description [Variation Report for NM_000796.6(DRD3):c.25G>A (p.Gly9Ser)]

NM_000796.6(DRD3):c.25G>A (p.Gly9Ser)

Gene:
DRD3:dopamine receptor D3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q13.31
Genomic location:
Preferred name:
NM_000796.6(DRD3):c.25G>A (p.Gly9Ser)
Other names:
S9G
HGVS:
  • NC_000003.12:g.114171968C>T
  • NG_008842.2:g.32440G>A
  • NM_000796.6:c.25G>AMANE SELECT
  • NM_001282563.2:c.25G>A
  • NM_001290809.1:c.25G>A
  • NM_033663.6:c.25G>A
  • NP_000787.2:p.Gly9Ser
  • NP_000787.2:p.Gly9Ser
  • NP_001269492.1:p.Gly9Ser
  • NP_001277738.1:p.Gly9Ser
  • NP_387512.3:p.Gly9Ser
  • NC_000003.11:g.113890815C>T
  • NM_000796.3:c.25G>A
  • NM_000796.5:c.25G>A
Protein change:
G9S; SER9GLY
Links:
OMIM: 126451.0001; dbSNP: rs6280
NCBI 1000 Genomes Browser:
rs6280
Molecular consequence:
  • NM_000796.6:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282563.2:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001290809.1:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033663.6:c.25G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Essential tremor, susceptibility to
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000038537OMIM
no assertion criteria provided
risk factor
(Mar 6, 2007)
germlineliterature only

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed.

Nöthen MM, Cichon S, Propping P, Fimmers R, Schwab SG, Wildenauer DB.

J Med Genet. 1993 Aug;30(8):708. No abstract available.

PubMed [citation]
PMID:
8411064
PMCID:
PMC1016510

A study of the association between schizophrenia and the dopamine D3 receptor gene.

Nanko S, Sasaki T, Fukuda R, Hattori M, Dai XY, Kazamatsuri H, Kuwata S, Juji T, Gill M.

Hum Genet. 1993 Oct;92(4):336-8.

PubMed [citation]
PMID:
8225313
See all PubMed Citations (7)

Details of each submission

From OMIM, SCV000038537.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (7)

Description

Crocq et al. (1992) presented data from 2 independent studies carried out in the UK and France, determining frequencies of a BalI polymorphism, ser9-to-gly (S9G), in the DRD3 gene in patients with schizophrenia (181500). In both studies, more patients than controls were homozygous (p = 0.005, p = 0.008). When pooled data were analyzed, this difference was highly significant (p = 0.0001) with a relative risk of schizophrenia in homozygotes of 2.61 (95% CI = 1.60-4.26).

Nothen et al. (1993) and Nanko et al. (1993) were unable to confirm the finding by Crocq et al. (1992) of an association between schizophrenia and homozygosity at the DRD3 receptor locus. However, Spurlock et al. (1998) did replicate the findings of Crocq et al. (1992) as part of the European Multicentre Association Study of Schizophrenia. An excess of homozygotes for both alleles of the DRD3 polymorphism was observed in schizophrenic patients (chi(2), 8.54, P = 0.003; odds ratio, 1.64, 95% CI, 1.18-2.29).

Lucotte et al. (2006) found that the DRD3 gly9 allele cosegregated with hereditary essential tremor (ETM1; 190300) in 23 of 30 unrelated French families. Parametric linkage analysis and transmission disequilibrium testing also showed significant positive association between the polymorphism and essential tremor. Among probands, gly9 homozygotes had significantly younger age at onset and more severe symptoms compared to heterozygotes, suggesting a gene dosage effect. Lucotte et al. (2006) noted that S9G occurs in the extracellular N terminus of the protein, which may increase dopamine affinity and efficacy. The authors hypothesized that essential tremor may result from a gain-of-function mechanism. By in vitro functional analysis in human embryonic kidney cells, Jeanneteau et al. (2006) found that the DRD3 gly9 allele had increased dopamine affinity, resulting in an increased intracellular response and prolonged protein kinase signaling compared to the ser9 allele, confirming a gain-of-function effect.

Tan et al. (2007) did not find an association between the gly9 allele and essential tremor among 163 sporadic Asian patients or 16 Asian families with essential tremor.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024